Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,627,000
+$351,961 QoQ
Shares Held
45,781
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#1,019
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Southeast Asset Advisors, LLC holds $26,273,942 across 7 Drug Manufacturers - General names. JNJ ranks #1 (44.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
45,781 | $11,627,000 | |
| 2 | ABBV |
AbbVie Inc.
|
21,450 | $5,397,678 | |
| 3 | LLY |
ELI LILLY & Co
|
2,848 | $3,415,976 | |
| 4 | PFE |
Pfizer Inc
|
99,468 | $2,395,189 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,706 | $1,632,721 | |
| 6 | NVS |
Novartis AG
|
6,716 | $1,052,531 | |
| 7 | AMGN |
Amgen Inc
|
2,079 | $752,847 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,627,000 | 45,781 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,275,039 | 46,126 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,562,538 | 46,207 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,928,714 | 48,154 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $6,413,514 | 41,987 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,485,007 | 39,104 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,478,639 | 37,883 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,980,320 | 49,243 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,246,028 | 49,576 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,840,370 | 49,563 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,755,965 | 49,483 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,731,585 | 49,641 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,184,208 | 55,487 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,774,240 | 56,608 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,854,420 | 55,785 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,275,744 | 56,781 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $10,172,033 | 57,304 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,211,992 | 57,620 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,847,815 | 57,566 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,334,861 | 57,801 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,556,567 | 58,010 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,304,510 | 56,614 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $9,138,427 | 58,066 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,597,373 | 57,747 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,184,666 | 58,200 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,563,316 | 57,678 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||